Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goodall

Showing results (261-270 of 308) with videos related to

Pageof 31
Sort By:
RNA (New York, N.Y.)|December 22, 2017
miR-222 isoforms are differentially regulated by type-I interferonCharlotte Nejad, Katherine A Pillman, Katherine J Siddle, et al.
Blood|January 1, 1996
Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonistQ Sun, J M Woodcock, A Rapoport, et al.
Oncogene|July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155P M Neilsen, J E Noll, S Mattiske, et al.
Journal of Cell Science|March 26, 2013
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like stateYat-Yuen Lim, Josephine A Wright, Joanne L Attema, et al.
Breast Cancer Research : BCR|June 18, 2015
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsBhupinder Pal, Yunshun Chen, Andrew Bert, et al.
British Journal of Cancer|September 11, 2003
The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcomaK K C Li, J Goodall, C R Goding, et al.
The Journal of Clinical Investigation|March 16, 2011
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in miceYanan Yang, Young-Ho Ahn, Don L Gibbons, et al.
Genome Research|November 4, 2010
Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptomeTim R Mercer, Marcel E Dinger, Cameron P Bracken, et al.
Oncogene|September 17, 2013
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathwaysX Li, S Roslan, C N Johnstone, et al.
The Journal of Clinical Investigation|August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionYoung-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Pageof 31

Showing results (261-270 of 308) with videos related to

Sort By:
Pageof 31
RNA (New York, N.Y.)|December 22, 2017
miR-222 isoforms are differentially regulated by type-I interferonCharlotte Nejad, Katherine A Pillman, Katherine J Siddle, et al.
Blood|January 1, 1996
Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonistQ Sun, J M Woodcock, A Rapoport, et al.
Oncogene|July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155P M Neilsen, J E Noll, S Mattiske, et al.
Journal of Cell Science|March 26, 2013
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like stateYat-Yuen Lim, Josephine A Wright, Joanne L Attema, et al.
Breast Cancer Research : BCR|June 18, 2015
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsBhupinder Pal, Yunshun Chen, Andrew Bert, et al.
British Journal of Cancer|September 11, 2003
The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcomaK K C Li, J Goodall, C R Goding, et al.
The Journal of Clinical Investigation|March 16, 2011
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in miceYanan Yang, Young-Ho Ahn, Don L Gibbons, et al.
Genome Research|November 4, 2010
Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptomeTim R Mercer, Marcel E Dinger, Cameron P Bracken, et al.
Oncogene|September 17, 2013
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathwaysX Li, S Roslan, C N Johnstone, et al.
The Journal of Clinical Investigation|August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionYoung-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Pageof 31